Publications

Insights

FDA issues final orders classifying radiological image analyzers and related software
Registered Content

On 22 January 2020 the U.S. Food and Drug Administration (FDA or the agency) published three regulations formally classifying certain radiological image analyzers and related software,...

Hogan Lovells Publications

Employment News: sexual harassment, bereavement leave, disability

Weekly newsletter on employment matters.

Insights

Tom Kabinet: CJEU rules resale of e-books requires permission of copyright holder
Registered Content

The CJEU in its Tom Kabinet judgment has ruled that the supply of e-books qualifies as "an act of communication to the public" under the InfoSoc Directive instead of "a...

Hogan Lovells Publications

Quarterly Corporate / M&A Decisions Update Series Corporate and M&A Decisions Update

These updates are designed to highlight selected important M&A, corporate and commercial court decisions on a quarterly basis. The updates contain brief summaries of each decision with...

Hogan Lovells Publications

Brexit FAQs: Entering the transition period - 31 January 2020

On 31 January 2020, the UK will formally leave the European Union, after over 40 years of membership. The UK’s relationship with the EU will no longer be governed by the EU Treaties,...

Hogan Lovells Publications

Doing Business – Consumer Sector

Entering a new market can be a game changer for businesses in the consumer industry, but it can come with some significant legal risks. Consumer protection laws, supply chain issues,...

Hogan Lovells Publications

FIG Bulletin, 24 January 2020

We are delighted to send you our latest e-newsletter, setting out recent regulatory developments of interest to financial institutions.

Published Works

Thinking ahead: Distressed M&A in uncertain times

Almost a decade into the current bull market, many economic prognosticators are warning of a coming downturn. At the same time, political upheaval and uncertainty around the world is...

Insights

The importance of conscientious health data collection in European clinical trials
Registered Content

Clinical trials have become increasingly important for pharmaceutical companies and medical device manufacturers, which are focused on collecting as much data as possible on products and...

Loading data